Swedbank Ab United Therapeutics Corp Transaction History

Swedbank Ab

$77.1 Billion
Q3 2024

A detailed history of Swedbank Ab transactions in United Therapeutics Corp stock. As of the latest transaction made, Swedbank Ab holds 414,937 shares of UTHR stock, worth $149 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

414,937

Previous 422,655 1.83%

Holding current value

$149 Million

Previous $135 Million 10.44%

% of portfolio

0.19%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$311.04 - $363.55 $2.4 Million - $2.81 Million	-7,718 Reduced 1.83%	414,937 $149 Million
Q2 2024 Jul 18, 2024	SELL	$228.26 - $319.04 $222,553 - $311,064	-975 Reduced 0.23%	422,655 $135 Million
Q1 2024 May 21, 2024	BUY	$210.76 - $249.51 $89.3 Million - $106 Million	423,630 New	423,630 $97.3 Billion
Q4 2023 Dec 09, 2024	SELL	$214.88 - $256.94 $1.03 Million - $1.23 Million	-4,780 Reduced 1.14%	413,167 $90.9 Million
Q3 2023 Dec 09, 2024	BUY	$211.82 - $248.24 $2.68 Million - $3.14 Million	12,645 Added 3.12%	417,947 $94.4 Million
Q2 2023 Dec 09, 2024	SELL	$205.19 - $232.99 $570,223 - $647,479	-2,779 Reduced 0.68%	405,302 $89.5 Million
Q1 2023 Dec 09, 2024	SELL	$212.99 - $276.17 $364,212 - $472,250	-1,710 Reduced 0.42%	408,081 $91.4 Million
Q4 2022 Dec 09, 2024	SELL	$205.95 - $280.43 $573,364 - $780,717	-2,784 Reduced 0.67%	409,791 $114 Million
Q2 2022 Dec 09, 2024	SELL	$174.81 - $241.14 $1.16 Million - $1.6 Million	-6,643 Reduced 1.58%	412,575 $97.2 Million
Q1 2022 Dec 09, 2024	BUY	$166.16 - $213.96 $1.01 Million - $1.31 Million	6,104 Added 1.48%	419,218 $75.2 Million
Q1 2021 Dec 09, 2024	BUY	$153.94 - $174.85 $63.6 Million - $72.2 Million	413,114 New	413,114 $69.1 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account